Dirction:Tyr-Somatostatin-14 (GT-P1731, CAS 58100-03-1) is a synthetic peptide with a disulfide bridge between Cys4 and Cys15. Its formula is C₈₅H₁₁₃N₁₉O₂₁S₂ and MW 1801.09. Manufactured via solid-phase peptide synthesis, it is supplied for endocrine and somatostatin receptor related academic research with reliable purity.

ຂໍ້ມູນພື້ນຖານ:
ຍີ່ຫໍ້: ການຂະຫຍາຍແຂງ
ລັກສະນະລັກສະນະ:ສີຂາວຜົງ
ການເກັບຮັກສາ: ຮົ່ມ, ເຢັນການອົບແຫ້ງ,ຄວາມບໍລິສຸດການເກັບຮັກສາປະທັບຕາ: ≥ 99% ການນໍາໃຊ້ຕົ້ນຕໍ: ການນໍາໃຊ້ການຄົ້ນຄວ້າ Polypeptide
ການປະຕິບັດມາດຕະຖານ: ມາດຕະຖານວິສາຫະກິດ
ຂໍ້ມູນສະເພາະ:mg/g/kg, ແລະອື່ນໆ (ຂຶ້ນກັບຄວາມຕ້ອງການຂອງລູກຄ້າ)
ຂອບເຂດການຂາຍ: ທົ່ວໂລກ
peptide ຄໍາຖາມທີ່ຖາມເລື້ອຍໆ:
1. How to judge whether the quality of peptide synthesis is qualified?
Each polypeptide will come: -HPLC chromatogram (purity test) -MS (Molecular Weight Verification) after the customer receives it, it can be verified again in combination with the experimental requirements, and can be retested and confirmed if necessary.
2. ການດັດແປງໃດທີ່ສະຫນັບສະຫນູນ? ການດັດແປງມີຜົນກະທົບຕໍ່ວົງຈອນບໍ?
Supporting modifications include, but are not limited: -Fluorescent labeling (FITC, Cy5, etc.) -Cyclization, phosphorylation, fatty acid -Biotinylation, C- terminal amidation, N-terminal acetylation, etc. Complex modification will appropriately extend the synthesis cycle, generally 7 to 12 working days, it is recommended to evaluate in advance.